Qairnel’s mission is to accelerate the arrival of new treatments for neurodegenerative diseases. Built on 15+ years of world-leading research at the Paris Brain Institute and Pitié-Salpêtrière hospital, Qairnel leverages AI and neuroscience to optimize clinical trials for Alzheimer’s. Its advancing screening product, DocMemo, enables early detection and precise patient profiling in the general population, before they enter the healthcare system. The patient-facing website DocMemo helps anyone with memory complaints evaluate their condition and navigate the healthcare system. It enables Qairnel to collect relevant medical data and identify potential trial candidates. 

Qairnel

Org chart

Teams

Offices

Qairnel

Org chart

Teams

Offices

Related companies